Committee header
Active cycles
Panel 2 • Finance overview
Committee finance snapshot
Scope: All time
Money over time
Panel 3 • Money structure snapshot
Money structure snapshot
$5,000+ is the largest bucket at 100% of total raised.
Dominant category: Media at 82.8% of spending.
Donor count
30
Contributions
59
Median
$175,000
Average
$1,364,990
Funding distribution
$5,000+
Count: 56
Share: 100%
Amount: $80,529,400
$1,000 - $4,999
Count: 2
Share: 0%
Amount: $5,000
$1 - $99
Panel 5 • Financial evidence
Filings workspace
Filing history and transaction-level evidence moved to a dedicated page.
Open filings pageCommittee header
Active cycles
Panel 2 • Finance overview
Committee finance snapshot
Scope: All time
Money over time
Panel 3 • Money structure snapshot
Money structure snapshot
$5,000+ is the largest bucket at 100% of total raised.
Dominant category: Media at 82.8% of spending.
Donor count
30
Contributions
59
Median
$175,000
Average
$1,364,990
Funding distribution
$5,000+
Count: 56
Share: 100%
Amount: $80,529,400
$1,000 - $4,999
Count: 2
Share: 0%
Amount: $5,000
$1 - $99
Panel 5 • Financial evidence
Filings workspace
Filing history and transaction-level evidence moved to a dedicated page.
Open filings pageCount: 1
Share: 0%
Amount: $1
Spending categories
Media
Amount: $88,402,904
Share: 82.8%
Operations
Amount: $9,460,355
Share: 8.9%
Consulting
Amount: $6,666,721
Share: 6.2%
Field
Amount: $2,217,453
Share: 2.1%
Count: 1
Share: 0%
Amount: $1
Spending categories
Media
Amount: $88,402,904
Share: 82.8%
Operations
Amount: $9,460,355
Share: 8.9%
Consulting
Amount: $6,666,721
Share: 6.2%
Field
Amount: $2,217,453
Share: 2.1%
Panel 4 • Top donors
Top donors
| Donor | Total | Share* | Count | Last |
|---|---|---|---|---|
| GLAXOSMITHKLINE | $9,840,600 | 12.2% | 2 | Jun 21, 2005 |
| JOHNSON & JOHNSON | $9,840,600 | 12.2% | 2 | Aug 1, 2005 |
| MERCK & CO., INC. | $9,840,600 | 12.2% | 2 | Jul 5, 2005 |
| PFIZER, INC. | $9,840,600 | 12.2% | 2 | Jun 30, 2005 |
| AMGEN INC. | $4,642,500 | 5.8% | 4 | Oct 4, 2005 |
| ABBOTT LABORATORIES | $4,558,500 | 5.7% | 3 | Jan 26, 2006 |
| ASTRAZENECA LP | $4,548,501 | 5.6% | 3 | Aug 25, 2005 |
| AVENTIS PHARMACEUTICALS, INC. | $4,548,500 | 5.6% | 2 | Sep 12, 2005 |
| BRISTOL-MYERS SQUIBB COMPANY | $4,548,500 | 5.6% | 3 | Jul 15, 2005 |
| ELI LILLY AND COMPANY | $4,548,500 | 5.6% | 2 | Jun 27, 2005 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $4,548,500 | 5.6% | 2 | Jul 5, 2005 |
| WYETH | $4,548,500 | 5.6% | 2 | Aug 4, 2005 |
| BOEHRINGER INGELHEIM PHARMACEUTICALS | $830,000 | 1% | 2 | Jul 28, 2005 |
| HOFFMAN-LA ROCHE INC. | $830,000 | 1% | 2 | Jun 30, 2005 |
| SCHERING CORPORATION | $830,000 | 1% | 2 | Jul 1, 2005 |
| BAYER CORPORATION | $255,000 | 0.3% | 2 | Jul 13, 2005 |
| ORGANON USA INC. | $255,000 | 0.3% | 2 | Jul 5, 2005 |
| SCHWARZ PHARMA | $255,000 | 0.3% | 2 | Jul 5, 2005 |
| SEPRACOR | $255,000 | 0.3% | 2 | Jul 18, 2005 |
| SERONO, INC. | $255,000 | 0.3% | 2 | Oct 7, 2005 |
| ASTELLAS US LLC | $175,000 | 0.2% | 1 | Jul 22, 2005 |
| SERONO, INC. | $175,000 | 0.2% | 1 | Oct 7, 2005 |
| VALEANT PHARMACEUTICAL, INC. | $155,000 | 0.2% | 2 | Aug 5, 2005 |
| SOLVAY PHARMACEUTICALS | $90,000 | 0.1% | 2 | Aug 9, 2005 |
| BERLEX LABORATORIES, INC. | $80,000 | 0.1% | 1 | Mar 2, 2005 |
* Share is percent of committee total raised in the selected scope. Page rows are a subset and typically do not sum to 100%.
Panel 4 • Top donors
Top donors
| Donor | Total | Share* | Count | Last |
|---|---|---|---|---|
| GLAXOSMITHKLINE | $9,840,600 | 12.2% | 2 | Jun 21, 2005 |
| JOHNSON & JOHNSON | $9,840,600 | 12.2% | 2 | Aug 1, 2005 |
| MERCK & CO., INC. | $9,840,600 | 12.2% | 2 | Jul 5, 2005 |
| PFIZER, INC. | $9,840,600 | 12.2% | 2 | Jun 30, 2005 |
| AMGEN INC. | $4,642,500 | 5.8% | 4 | Oct 4, 2005 |
| ABBOTT LABORATORIES | $4,558,500 | 5.7% | 3 | Jan 26, 2006 |
| ASTRAZENECA LP | $4,548,501 | 5.6% | 3 | Aug 25, 2005 |
| AVENTIS PHARMACEUTICALS, INC. | $4,548,500 | 5.6% | 2 | Sep 12, 2005 |
| BRISTOL-MYERS SQUIBB COMPANY | $4,548,500 | 5.6% | 3 | Jul 15, 2005 |
| ELI LILLY AND COMPANY | $4,548,500 | 5.6% | 2 | Jun 27, 2005 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $4,548,500 | 5.6% | 2 | Jul 5, 2005 |
| WYETH | $4,548,500 | 5.6% | 2 | Aug 4, 2005 |
| BOEHRINGER INGELHEIM PHARMACEUTICALS | $830,000 | 1% | 2 | Jul 28, 2005 |
| HOFFMAN-LA ROCHE INC. | $830,000 | 1% | 2 | Jun 30, 2005 |
| SCHERING CORPORATION | $830,000 | 1% | 2 | Jul 1, 2005 |
| BAYER CORPORATION | $255,000 | 0.3% | 2 | Jul 13, 2005 |
| ORGANON USA INC. | $255,000 | 0.3% | 2 | Jul 5, 2005 |
| SCHWARZ PHARMA | $255,000 | 0.3% | 2 | Jul 5, 2005 |
| SEPRACOR | $255,000 | 0.3% | 2 | Jul 18, 2005 |
| SERONO, INC. | $255,000 | 0.3% | 2 | Oct 7, 2005 |
| ASTELLAS US LLC | $175,000 | 0.2% | 1 | Jul 22, 2005 |
| SERONO, INC. | $175,000 | 0.2% | 1 | Oct 7, 2005 |
| VALEANT PHARMACEUTICAL, INC. | $155,000 | 0.2% | 2 | Aug 5, 2005 |
| SOLVAY PHARMACEUTICALS | $90,000 | 0.1% | 2 | Aug 9, 2005 |
| BERLEX LABORATORIES, INC. | $80,000 | 0.1% | 1 | Mar 2, 2005 |
* Share is percent of committee total raised in the selected scope. Page rows are a subset and typically do not sum to 100%.